TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

90.80$ -7.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

GeneDx Holdings Corp. (WGS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 481 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet WGS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
417 419 395 389 409 419 446 464 494 570 506 481
172 182 163 162 186 198 226 205 238 268 271 246
87 100 84 56 58 85 100 74 96 105 94 60
114 130 113 107 116 141 159 135 155 171 171 133
32 33 29 26 38 38 46 48 61 74 77 84
9.3 8.8 12 10 11 11 13 12 11 14 12 18
0.0 13 13 14 1.6 1.6
176 173 169 166 162 159 155 177 173 168 145 141
163 191 187 195 204 174 189 187 202 262 252 237
68 59 51 68 77 55 70 71 88 109 88 75
3.9 4.1 8.9 4.0 3.7 3.3 3.1 3.1 4.4 8.9 5.1 5.7
15 10 9.5 8.1 9.0 8.0 16 3.5 2.6 2.5 11 5.1
6.1 53 52 52 52 52 52 52 52 48 97 97
254 228 207 194 205 245 257 277 292 308 254 244
-1,274 -1,300 -1,320 -1,350 -1,358 -1,352 -1,359 -1,348 -1,356 -1,373 -1,437 -1,455
26 26 26 27 27 27 28 30 29 27 29 30

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?